These results align with a previous study conducted in patients with gastrointestinal disorders treated with omeprazole, where therapeutic failure was associated with the CYP2C:TG/TG diplotype, but not with the increased-function variant CYP2C19*17 [19]. Here, CYP2C18 is linked to digestive system disorder.